As of 2025-05-17, the Intrinsic Value of SD Biotechnologies Co Ltd (217480.KQ) is (5,423.77) KRW. This 217480.KQ valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 349.00 KRW, the upside of SD Biotechnologies Co Ltd is -1,654.10%.
The range of the Intrinsic Value is (33,541.60) - (3,287.24) KRW
Based on its market price of 349.00 KRW and our intrinsic valuation, SD Biotechnologies Co Ltd (217480.KQ) is overvalued by 1,654.10%.
Note: result may not be accurate due to the invalid valuation result of DCF model.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | (33,541.60) - (3,287.24) | (5,423.77) | -1654.1% |
| DCF (Growth 10y) | (3,908.67) - (38,377.09) | (6,355.39) | -1921.0% |
| DCF (EBITDA 5y) | (574.62) - (329.37) | (1,234.50) | -123450.0% |
| DCF (EBITDA 10y) | (1,289.69) - (1,176.34) | (1,234.50) | -123450.0% |
| Fair Value | -1,675.04 - -1,675.04 | -1,675.04 | -579.95% |
| P/E | (3,430.48) - (3,738.69) | (3,601.34) | -1131.9% |
| EV/EBITDA | (2,437.85) - 301.96 | (1,360.44) | -489.8% |
| EPV | (5,391.29) - (6,980.36) | (6,185.82) | -1872.4% |
| DDM - Stable | (2,786.76) - (11,976.93) | (7,381.84) | -2215.1% |
| DDM - Multi | (1,898.73) - (6,673.95) | (2,995.63) | -958.3% |
| Market Cap (mil) | 14,870.89 |
| Beta | 0.88 |
| Outstanding shares (mil) | 42.61 |
| Enterprise Value (mil) | 36,562.89 |
| Market risk premium | 5.82% |
| Cost of Equity | 9.47% |
| Cost of Debt | 4.27% |
| WACC | 6.17% |